Related references
Note: Only part of the references are listed.Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
Characterization of Genetically Modified T-Cell Receptors that Recognize the CEA:691-699 Peptide in the Context of HLA-A2.1 on Human Colorectal Cancer Cells
Maria R. Parkhurst et al.
CLINICAL CANCER RESEARCH (2009)
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Steven A. Rosenberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Efficient Human Hematopoietic Cell Transduction Using RD114-and GALV-Pseudotyped Retroviral Vectors Produced in Suspension and Serum-Free Media
Karim Ghani et al.
HUMAN GENE THERAPY (2009)
Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor
James N. Kochenderfer et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Characterization of a novel nonclassical T cell clone with broad reactivity against human renal cell carcinomas
Qiong J. Wang et al.
JOURNAL OF IMMUNOLOGY (2008)
Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media
K. Ghani et al.
GENE THERAPY (2007)
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes
Laura A. Johnson et al.
JOURNAL OF IMMUNOLOGY (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability
Cyrille J. Cohen et al.
CANCER RESEARCH (2006)
Production scale-up and validation of packaging cell clearance of clinical-grade retroviral vector stocks produced in Cell Factories
M Przybylowski et al.
GENE THERAPY (2006)
Retroviral vector production in the National Gene Vector Laboratory at Indiana University
K Cornetta et al.
GENE THERAPY (2005)
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions
MS Hughes et al.
HUMAN GENE THERAPY (2005)
Production of retrovirus and adenovirus vectors for gene therapy: A comparative study using microcarrier and stationary cell culture
SC Wu et al.
BIOTECHNOLOGY PROGRESS (2002)
Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors
M Pizzato et al.
GENE THERAPY (2001)
Clinical retroviral vector production: step filtration using clinically approved filters improves titers
L Reeves et al.
GENE THERAPY (2000)
Packaging cell line characteristics and optimizing retroviral vector titer: The National Gene Vector Laboratory Experience
L Reeves et al.
HUMAN GENE THERAPY (2000)
Share Paper
